Multisystem Langerhans cell histiocystosis in a geriatric patient: case report
DOI:
https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20221832Keywords:
Histiocytosis, Langerhans cells, Langerhans cell histiocytosis in adultsAbstract
Langerhans cell histiocytosis is a condition of exceptional onset characterized by a proliferative event of dendritic cells with mono or multisystem involvement that predominates in the pediatric population and is identified in a smaller proportion in adults. It has a clinical impact and variable prognosis according to its location and number of organs affected. A 68-year-old male patient with clinical and immunohistochemical criteria for Langerhans cell histiocytosis with multisystem settlement with fatal outcome. It is a very rare disease, it is not exclusive to the pediatric population, with little understood pathogenesis and does not have specific treatment. In adults, the clinical impact is more aggressive, with a poorer prognosis and greater short-term complications.
Metrics
References
Allen CE, Merad M, McClain KL. Langerhans-Cell Histiocytosis. N Engl J Med. 2018;379(9):856-68.
Kobayashi M, Tojo A. Langerhans cell histiocytosis in adults: Advances in pathophysiology and treatment. Cancer Sci. 2018;109(12):3707-13.
Krooks J, Minkov M, Weatherall AG. Langerhans cell histiocytosis in children: History, classification, pathobiology, clinical manifestations, and prognosis. J Am Acad Dermatol. 2018;78(6):1035-44.
Badalian-Very G, Vergilio JA, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood. 2010;116(11):1919-23.
Roden AC, Hu X, Kip S, Parrilla Castellar ER, Rumilla KM, Vrana JA, et al. BRAF V600E expression in Langerhans cell histiocytosis: clinical and immunohistochemical study on 25 pulmonary and 54 extrapulmonary cases. Am J Surg Pathol. 2014;38(4):548-51.
Berres ML, Lim KP, Peters T, Price J, Takizawa H, Salmon H, et al. BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups. J Exp Med. 2014;211(4):669-83.
Gasent Blesa JM, Alberola Candel V, Solano Vercet C, Laforga Canales J, Semler C, Pérez Antolí MR, Rodríguez-Galindo C. Langerhans cell histiocytosis. Clin Transl Oncol. 2008;10(11):688-96.
Gallego CT, Bueno J, Cruces E, Stelow EB, Mancheño N, Flors L. Pulmonary histiocytosis: beyond Langerhans cell histiocytosis related to smoking. Radiologia (Engl Ed). 2019;61(3):215-24.
Monsereenusorn C, Rodriguez-Galindo C. Clinical Characteristics and Treatment of Langerhans Cell Histiocytosis. Hematol Oncol Clin North Am. 2015;29(5):853-73.
Zhao M, Tang L, Sun S, Cui J, Chen H. Radiologic findings that aid in the reduction of misdiagnoses of Langerhans cell histiocytosis of the bone: a retrospective study. World J Surg Oncol. 2021;19(1):146.
Schär RT, Hewer E, Ulrich CT. Langerhans Cell Histiocytosis of the Adult Cervical Spine: A Case Report and Literature Review. J Neurol Surg A Cent Eur Neurosurg. 2019;80(1):49-52.
Gasent Blesa JM, Alberola Candel V, Solano Vercet C, Laforga Canales J, Semler C, Pérez Antolí MR, Rodríguez-Galindo C. Langerhans cell histiocytosis. Clin Transl Oncol. 2008;10(11):688-96.
Cipolla F, Ragusa M, Bannò V, La Mantia I, Andaloro C. Langerhans Cell Histiocytosis of the Tonsil. Balkan Med J. 2022;39(1):66-7.
Radzikowska E. Pulmonary Langerhans' cell histiocytosis in adults. Adv Respir Med. 2017;85(5):277-89.
Mansour MJ, Mokbel E, Fares E, Maddah J, Nasr F. Adult Langerhans cell histiocytosis with pulmonary and colorectoanal involvement: a case report. J Med Case Rep. 2017;11(1):272.
Schär RT, Hewer E, Ulrich CT. Langerhans Cell Histiocytosis of the Adult Cervical Spine: A Case Report and Literature Review. J Neurol Surg A Cent Eur Neurosurg. 2019;80(1):49-52.
Takase R, Nakano Y, Morizane S, Otsuka F. Hypothalamic Mass Detected in Langerhans Cell Histiocytosis. Intern Med. 2021;60(11):1795.
Gholami N. Pericardial Effusion in Langerhans Cell Histiocytosis: A Case Report. Iran Red Crescent Med J. 2016;18(6):e25604.